CPHI & PMEC China 2026
06/2026 – 06/2026
About Company
- Legal Name: ZHEJIANG JINGXIN PHARMACEUTICAL CO.LTD.
- Registered country: China
- Address: No.800, Dadao East Road,Chengguan, Zhejiang
- Established year: 1990
Description:
Jingxin Pharm is a producer of APIs such as Simvastatin, Levofloxacin Hemihydrate, Ciprofloxacin HCl, Gatifloxacin, and Enrofloxacin Base and HCl, as well as finished dosage forms such as tablets, capsules and injections. Jingxin Pharm holds EDMF and US DMF filings for all products, and its formulation factory has received German GMP approval.
Business Activities
Finished Dosage Forms
Manufacturer
Excipients & Additives
Manufacturer
Sales Markets
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Northern Europe: Denmark, Estonia, Finland, Iceland
Our Products & Services
Proofs
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment